Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care?
about
Changing the treatment of heart failure with reduced ejection fraction: clinical use of sacubitril-valsartan combinationResetting the neurohormonal balance in heart failure (HF): the relevance of the natriuretic peptide (NP) system to the clinical management of patients with HFGlobal left atrial failure in heart failure.A comparison of the prognostic value of BNP versus NT-proBNP after hospitalisation for heart failure
P2860
Will sacubitril-valsartan diminish the clinical utility of B-type natriuretic peptide testing in acute cardiac care?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Will sacubitril-valsartan dimi ...... testing in acute cardiac care?
@en
type
label
Will sacubitril-valsartan dimi ...... testing in acute cardiac care?
@en
prefLabel
Will sacubitril-valsartan dimi ...... testing in acute cardiac care?
@en
P2093
P2860
P356
P1476
Will sacubitril-valsartan dimi ...... testing in acute cardiac care?
@en
P2093
Allan S Jaffe
Bertil Lindahl
Biomarker Study Group of the E ...... ardiovascular Care Association
Christian Müller
Evangelos Giannitsis
Johannes Mair
Kristian Thygesen
Kurt Huber
Mario Plebani
Martin Möckel
P2860
P304
P356
10.1177/2048872615626355
P577
2016-01-12T00:00:00Z